No registrations found.
ID
Source
Brief title
Health condition
PTSD
childhoodtrauma
Exposure
Rescripting
Sponsors and support
https://pm-psychotherapieamsterdam.nl
https://pm-psychotherapieamsterdam.nl
Intervention
Outcome measures
Primary outcome
Primary outcome measure is severity of PTSD symptoms, as assessed with the Post-Traumatic Stress Diagnostic Scale PDS (self-report) (Foa, Riggs, Dancu, & Rothbaum, 1993; Arntz, 1993), Dutch version.
Secondary outcome
• Drop out during study
• Severity of PTSD symptoms as assessed with the Clinician - Administered PTSD Scale (CAPS-DX, KIP) Self-report questionnaires:
• Anger Expression Scale (AEQ)
• State-Trait Anger Inventory (ZAV)
• Guilt scale Kubany
• Shame scale Smucker
• Brief Symptom Inventory (BSI)
• Beck Depression Inventory (BDI - II)
• Difficulties in Emotion Regulation Scale (DERS) (Gratz and Roemer, 2004)
• PTCI: Posttraumatic Cognitions Inventory (Foa, Ehlers, Clark, Tolin & Orsillo 1999, from Emmerich, Schoorl, Emmelkamp & Kamphuis, 2006)
• Self-image Rosenberg
Background summary
Meta-analyses show that Trauma-Focused Cognitive Behavioral, Imaginary Exposure and Eye Movement Desensitization-Reprocessing are the most effective psychological treatments for posttraumatic stress disorder (PTSD) (Bisson et al, 2007; Bradley, Greene, Russ, Dutra & West, 2005; Cloitre, 2009; Seidler & Wagner, 2006). These relatively short treatments (9-12 sessions of 90 minutes) results in a considerable reduction of PTSD symptoms in 40-70% of patients. However, the vast majority of research has been conducted on PTSD following a single traumatic event. Research examining the application of these two protocols to PTSD as a result of repeated and prolonged interpersonal abuse in childhood (eg sexual and / or physical abuse) within the immediate environment is scant. Whether Imaginary Exposure should be regarded a ‘golden standard treatment’ in this patient group is unknown, en thus, research examining the effectiveness of Imaginary Exposure in this patient group is needed. Moreover, a novel treatment called ‘Imaginary Rescripting’ may more actively intervene in key processes that play a role in the development of PTSD such as dysfunctional based schedules and tonic immobility (TI). Hence, it may be more effective as compared to Imaginary Exposure.
This study focuses on PTSD due to repeated and prolonged interpersonal abuse in childhood (eg sexual and / or physical abuse) within the immediate environment. By using a
Randomized controlled design, we examine whether Imaginary Exposure is more effective as compared to a waitinglist with regard to severity of PTSD symptoms, and whether Imaginaire Rescripting is more effective as compared to Imaginary Exposure.
Study objective
This study focuses on PTSD due to repeated and prolonged interpersonal abuse in childhood (eg sexual and / or physical abuse) within the immediate environment. By using a
Randomized controlled design, we examine whether Imaginary Exposure is more effective as compared to a waitinglist with regard to severity of PTSD symptoms, and whether Imaginaire Rescripting is more effective as compared to Imaginary Exposure.
Primary hypotheses:
We expect that in this patient group with repeated and prolonged interpersonal abuse in childhood within the immediate environment, Imaginary Exposure will be more effective as compared to a waiting list condition.
Moreover, we expect that Imaginary Rescripting is more effective as compared to Imaginary exposure, based on the hypothesis that Imaginary Rescripting more actively intervenes in key pathological processes in PTSD.
Secondary hypotheses:
- We expect that ImRes is less heavy for patients as compared to IE, thus expecting drop-outs to be lower in the ImRes group as compared to the IE group
- We expect that for those with a higher ‘Tonic Immobility Score’, ImRes is more effective as compared to IE, because ImRes directly focuses on TI.
- We expect that for those with higer dissociation scores, ImRes is more effective.
- We expect that emotion-regulation will improve more in the ImRes group as compared to the IE group, as ImRes not only focuses on fear but also explicitly on other emotions.
- We expect self-image to improve more in the ImRes condition as compared to the IE condition, as this intervention focuses more explicitly on the UCS/UCR representation.
Study design
• Measurement 1: After inclusion, so at the start of treatment
• Measurement 2: After 11 weeks (ending therapy)
• Measurement 3: At follow-up, 6 months after measurement 2
Intervention
This study is a randomized controlled trial with three conditions, i.e. Waiting list (WL), Imaginary Exposure (IE), Imaginary Rescripting (ImRes).
Treatment duration is 11 weeks, during the first 5 weeks 2 sessions of 90 minutes each will be provided, followed by 6 weeks of one 90 minute session.
In the treatment conditions, homework of maximum 1 hr per week is given.
No sessions for the waitinglist will be provided.
P.M. Jong, de
Psychotherapy & Moment
drs. P.M. de Jong & M.T.C van Hemert
Sarphatistraat 27a
Amsterdam 1018 EV
The Netherlands
0031 (0) 20- 528 52 31
info@psychotherapymovement.nl
P.M. Jong, de
Psychotherapy & Moment
drs. P.M. de Jong & M.T.C van Hemert
Sarphatistraat 27a
Amsterdam 1018 EV
The Netherlands
0031 (0) 20- 528 52 31
info@psychotherapymovement.nl
Inclusion criteria
1. Meeting DSM-IV criteria for PTSD
2. Comorbidity with depression, anxiety disorder, ADHD, dissociative disorder, reactive psychotic disorder, alcohol/drugs consumption, borderline personality disorder and cluster C personality disorder are included.
3. Having experienced repeated or chronic interpersonal trauma before age of 16 (e.g. sexual, physical or emotional abuse) by one or more perpetrators for example (foster-/step-) parents, elder brother, sister, uncle, aunt, nephew, niece, friend of parents, someone from the neighbourhood, school, sport, institution, church and give minimal two examples. Age difference is 5 years with the perpetrator.
4. At least 18 years of age till 85 years old.
5. Sufficient fluency in Dutch to complete treatment and research protocol
6. Participants using antidepressant medication are required to be a stable dose for at least 3 months before the beginning of the treatment and remain on this dose throughout the treatment. The same applies for benzodiazepinens with a maximum of 30 mg oxazepam equivalents.
7.Signed informed consent
Exclusion criteria
1. Other psychiatric treatments
2. Schizophrenia, active suicidality, dissociative identity disorder, mentally retarded
3. No fixed residence, major financial problems, , no aid figure, problems with justice and law, current sexual and physical abuse
4. Use of other psychotropic drugs than antidepressants and benzodiazepines.
5. Insufficient fluency in Dutch
Design
Recruitment
IPD sharing statement
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
NTR-new | NL4665 |
NTR-old | NTR4817 |
Other | - : - |